Latest in FAIM
iiiiiiiii
May 1, 2023
Artificial intelligence is transforming the field of medicine, offering new opportunities to improve patient care, diagnosis, treatment...
May 1, 2023
Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation–Related Stroke...
May 1, 2023
Daysy® has been developed as a medical device to track your fertility days, helping understand menstrual cycles and ovulation days...
May 1, 2023
Artificial Intelligence Tool Diagnose Alzhemeir’s with 95% Accuracy, AI cleared for predicting ICU patient decline...
May 1, 2023
NovaSignal primarily aims to give doctors more access to vital data they need to better their patients' lives through advanced technology.
May 1, 2023
Image and speech recognition, self-driving cars, object detection, and much more is what Deep Learning technology accomplishes for us...
May 1, 2023
Turkey's AI efforts aim to become a global AI leader, facing various challenges and seizing opportunities...
May 1, 2023
Freenome is an up-and-coming biotechnology company that is revolutionizing cancer screening and offering new alternatives to the future of oncology...
April 1, 2023
Exoskeleton robot that assists patients with partial or complete lower extremity paralysis by providing realistic gait training on real-world terrain...
Expert Interview
Dr. Sameer Mehta
Editor-In Chief & Founder
Sameer Mehta, MD, FACC, MBA, is a U.S. interventional cardiologist
Journal Club
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens
JAMA Network Open – Oncology – May 13, 2020
SIGN UP FOR OUR NEWSLETTER
Join our subscribers list to get the latest news and updates directly in your inbox.
From Our Book
